| Medius AG - Pylera 140 mg/125 mg/125 mg, Hartkapseln | | 66366 | | 01 | | Pylera 140 mg/125 mg/125 mg | | Hartkapseln | | A02BD08 | | Bismuth Subcitrate, Tetracycline and Metronidazole | | 30.11.2017 | | |
| | Composition | | bismuthi subcitras kalicum 140 mg, metronidazolum 125 mg, tetracyclini hydrochloridum 125 mg, lactosum monohydricum 61 mg, talcum, magnesii stearas, Kapselhülle: E 171, gelatina, aqua purificata, Drucktinte: lacca, propylenglycolum, E 172 (rubrum), pro capsula corresp. kalium 35.06 mg. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Bismuthi Subcitras Kalicum | 140 mg | | Metronidazole | 125 mg | | Tetracycline Hydrochloride | 125 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Bismuthi Subcitras Kalicum | 140 mg | | Metronidazole | 125 mg | | Tetracycline Hydrochloride | 125 mg |
| | | | Agents auxilliaires |
|---|
| Pro Capsula |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 120 | 62.20 | 84.05 | A | LS | Oui |
|
|
